Reuters logo
BRIEF-Edge Therapeutics appoints Rosemary Crane to Board of Directors
September 19, 2017 / 11:21 AM / in a month

BRIEF-Edge Therapeutics appoints Rosemary Crane to Board of Directors

Sept 19 (Reuters) - Edge Therapeutics Inc

* Edge Therapeutics appoints Rosemary A Crane, pharmaceutical industry leader, to its Board Of Directors

* Edge Therapeutics Inc - ‍Crane’s appointment expands Board of Directors to 10 members, eight of whom are independent​

* Edge Therapeutics Inc - ‍Crane currently serves as a Director of Teva Pharmaceuticals and as vice chairman of Board of Zealand Pharma A/S​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below